A detailed history of Sanibel Captiva Trust Company, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Sanibel Captiva Trust Company, Inc. holds 80,304 shares of AMGN stock, worth $25.4 Million. This represents 0.83% of its overall portfolio holdings.

Number of Shares
80,304
Previous 80,938 0.78%
Holding current value
$25.4 Million
Previous $25.3 Billion 2.32%
% of portfolio
0.83%
Previous 0.86%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$309.38 - $337.38 $196,146 - $213,898
-634 Reduced 0.78%
80,304 $25.9 Billion
Q2 2024

Jul 22, 2024

SELL
$262.75 - $319.31 $490,817 - $596,471
-1,868 Reduced 2.26%
80,938 $25.3 Billion
Q1 2024

May 21, 2024

SELL
$268.87 - $324.56 $225,044 - $271,656
-837 Reduced 1.0%
82,806 $23.5 Billion
Q4 2023

Feb 16, 2024

BUY
$255.7 - $288.46 $21.4 Million - $24.1 Million
83,643 New
83,643 $24.1 Billion

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $170B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Sanibel Captiva Trust Company, Inc. Portfolio

Follow Sanibel Captiva Trust Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sanibel Captiva Trust Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sanibel Captiva Trust Company, Inc. with notifications on news.